Listed SSE IPO GCFZCZP

Grace Cancer Foundation IPO GMP & Allotment

Grace Cancer Foundation (GRACE – Global Research and Cancer Education) is a Hyderabad-based public charitable trust established on October 26, 2013, by medical professionals to alleviate the burden of cancer through accessible preventive healthcare. Operating primarily across Telangana, Andhra Pradesh, and Karnataka, alongside global partnerships, the Foundation anchors its operations on 4 core pillars: cancer prevention through community health awareness, early detection via mobile screening bus units and rural medical camps, treatment support and patient navigation for economically disadvantaged communities, and technological research including AI-driven screening tools. The Trust holds valid regulatory registrations under Sections 12AB and 80G of the Income Tax Act, 1961, and is registered under the Foreign Contribution (Regulation) Act (FCRA), 2010.

IPO Price Band
₹10.00 - ₹10.00
Lot Size
100 Shares
Bidding Closes
21 Oct 2026
Listing Date
TBA
Quick Answer & Highlights

Grace Cancer Foundation IPO GMP Today & Key Takeaways

Last updated: 30 Oct 2026

Grace Cancer Foundation IPO officially listed on TBA at Rs 10.00 compared to its issue price of Rs 10.00. Pre-listing, its final recorded Grey Market Premium (GMP) was -.

Key Metric Figure Status / Context
Current GMP - GMP update awaited
Est. Listing Price TBA TBA
Price Band ₹10.00 - ₹10.00 SSE IPO
Retail Minimum Investment ₹1,000 1 Lot (100 Shares)
Bidding Window 07 Oct 2026 – 21 Oct 2026 Listed
Allotment & Listing Dates Allotment: TBA Listing: TBA
Will you apply for this IPO?
Is this GMP accurate?
Current GMP Status
-
GMP update awaited
Est. Listing Gain TBA
Last Trend TBA
Listing Price TBA
Retail Entry ₹1,000
IPO Details

Complete IPO information

Grace Cancer Foundation IPO Details and Specifications
IPO Open Date 07 Oct 2026
IPO Close Date 21 Oct 2026
IPO Price Band ₹10.00 - ₹10.00
Lot Size 100 Shares
Current GMP -
Estimated Listing Gain TBA
Issue Size -
Fresh Issue -
Issue Type SSE
IPO Listing NSE, BSE
Retail Quota TBA
Registrar TBA
Overall Subscription TBA
Minimum Investment ₹1,000
DRHP Draft Prospectus -
RHP Draft Prospectus -
Analysis

IPO Snapshot & Investor Takeaways

At the upper end of its price band, Grace Cancer Foundation is priced at ₹10 per share. With a minimum lot size of 100 shares, a retail investor applying for one lot would need approximately ₹1,000 to participate in this SSE issue.

This issue lists on the Social Stock Exchange (SSE) platform, a segment dedicated to social enterprises and non-profit organizations rather than conventional for-profit listings.

Timeline

IPO roadmap at a glance

✓
Bidding Opens 07 Oct 2026
✓
Bidding Closes 21 Oct 2026
✓
Allotment TBA
✓
Listing TBA
Grace Cancer Foundation IPO Timeline and Important Dates Schedule
Event / Milestone Scheduled Date Status
Bidding Opens 07 Oct 2026 Completed
Bidding Closes 21 Oct 2026 Completed
Allotment TBA Completed
Listing TBA Completed
Market Lot

Application size breakdown

Grace Cancer Foundation IPO Market Lot & Application Breakdown
Category Lots Shares Amount
Retail Minimum 1 Lot 100 ₹1,000
Retail Maximum 200 Lot 20,000 ₹2,00,000
S-HNI Minimum 201 Lot 20,100 ₹2,01,000
S-HNI Maximum 1000 Lot 1,00,000 ₹10,00,000
B-HNI Minimum 1001 Lot 1,00,100 ₹10,01,000
Swipe to see more →
FAQ

Grace Cancer Foundation IPO FAQs

Grace Cancer Foundation IPO GMP today is TBA. Investors can use this GMP along with price band and subscription status for a better IPO review.
Grace Cancer Foundation IPO price band is Rs 10.00 to Rs 10.00. Check the latest issue price, lot size and GMP together before applying.
Grace Cancer Foundation IPO open date is 07 Oct 2026, close date is 21 Oct 2026, and listing date is TBA.
Grace Cancer Foundation IPO lot size is 100 shares. The minimum retail investment is Rs 1,000.
Grace Cancer Foundation is classified as a SSE IPO. This helps investors quickly understand the issue category and exchange segment.
Grace Cancer Foundation IPO subscription status currently shows Subscription data is currently awaited.
Grace Cancer Foundation (GRACE – Global Research and Cancer Education) is a Hyderabad-based public charitable trust established on October 26, 2013, by medical professionals to alleviate the burden of cancer through accessible preventive healthcare. Operating primarily across Telangana, Andhra Pradesh, and Karnataka, alongside global partnerships, the Foundation anchors its operations on 4 core pillars: cancer prevention through community health awareness, early detection via mobile screening bus units and rural medical camps, treatment support and patient navigation for economically disadvantaged communities, and technological research including AI-driven screening tools. The Trust holds valid regulatory registrations under Sections 12AB and 80G of the Income Tax Act, 1961, and is registered under the Foreign Contribution (Regulation) Act (FCRA), 2010.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
Community discussion

Comments

Share a useful question or insight about Grace Cancer Foundation.

Loading comments...

Leave a comment

Your email address will not be published. All comments and replies are reviewed before appearing.

Keep Exploring

Similar Recent IPOs

Related Topics
Grace Cancer Foundation IPOGrace Cancer Foundation GMPGrace Cancer Foundation IPO GMPGrace Cancer Foundation IPO GMP todayGrace Cancer Foundation grey market premiumGrace Cancer Foundation price bandGrace Cancer Foundation subscription statusGrace Cancer Foundation allotment statusGrace Cancer Foundation listing dateGrace Cancer Foundation lot sizeGrace Cancer Foundation IPO reviewGrace Cancer Foundation IPO listing gain estimateGrace Cancer Foundation GMP calculatorGrace Cancer Foundation IPO 2026